Lithium Americas (LAC) stock: U.S. critical-minerals push puts Thacker Pass back in focus next week

Lithium Americas (LAC) stock: U.S. critical-minerals push puts Thacker Pass back in focus next week

New York, Jan 11, 2026, 18:04 EST — Market closed.

  • Lithium Americas shares dropped roughly 2.4% on Friday ahead of U.S. markets reopening Monday.
  • Washington is pushing allies to accelerate efforts on supply chains for minerals dominated by China, such as lithium.
  • Investors are keeping an eye on lithium price benchmarks and Lithium Americas’ upcoming conference appearances later this month.

Lithium Americas Corp (LAC) shares are set to attract attention when U.S. markets open Monday, amid Washington’s efforts to curb dependence on China for key battery minerals. The stock slipped roughly 2.4% Friday, finishing at $5.39 after swinging between $5.31 and $5.64 on volume near 9.9 million shares.

This matters because the market is once again viewing lithium miners and developers through the lens of policy, not just as commodity bets. For Lithium Americas, the implications are clear: any shift in U.S. supply support or lithium price forecasts can send the stock moving sharply, even though the mine won’t produce for years.

Treasury Secretary Scott Bessent plans to meet finance officials Monday to push for quicker steps to reduce reliance on China for minerals critical to defense tech, semiconductors, and batteries, a senior U.S. official said. The official pointed out that China refines between 47% and 87% of key minerals like lithium and rare earths, referencing International Energy Agency data. However, they added no immediate joint measures are expected. (Reuters)

Lithium Americas is developing Thacker Pass in Nevada to bolster the U.S. lithium supply chain. Phase 1 aims to produce 40,000 tonnes annually of battery-grade lithium carbonate, with mechanical completion expected by late 2027. The project is supported by a $2.23 billion ATVM loan from the U.S. Department of Energy and a long-term offtake agreement with General Motors to purchase future output. (Lithium Americas)

Lithium prices edged higher into Friday. According to Shanghai Metals Market data, the battery-grade lithium carbonate index hit around $17,554 per metric ton on Jan. 9, marking a 1.52% daily gain. Meanwhile, the battery-grade lithium hydroxide index climbed roughly 3.1%. (Metal)

Monday’s focus is on headlines and tone: will the U.S. meeting deliver something actionable, or just another statement? Either outcome could ripple through battery-metal stocks, with Lithium Americas standing out as one of the more liquid U.S.-listed plays to watch.

However, the situation is double-edged. Should lithium prices slip back or appetite for risk wane, policy rhetoric alone might fail to sustain momentum. Thacker Pass also faces execution risks — any hold-ups, rising costs, or permitting hurdles could drive up funding requirements.

Lithium Americas is set to present at TD Cowen’s Metals & Mining Conference on Jan. 27. Investors will be watching closely for updates on construction progress, financing plans, and the timeline the company stands by. (Lithium Americas)

The company is also set to appear at BMO’s Metals & Mining Conference on Feb. 22. Before then, the immediate focus will be on how the market responds to Monday’s U.S. critical-minerals meeting when stocks reopen on Jan. 12. (Lithium Americas)

Stock Market Today

  • Profound Medical: Top TSX Growth Stock Poised for Rapid Expansion, Q3 Revenues Surge 87%
    February 1, 2026, 9:22 PM EST. Profound Medical (TSX:PRN), a Canadian medical device firm specializing in MRI-guided ultrasound therapies, is highlighted as the sole TSX growth stock to hold for the next three years. The company reported an 87% revenue increase in Q3 to $5.3 million, driven by expanded installations of its flagship TULSA-PRO prostate cancer treatment system. Offering incision-free, MRI-guided ablation technology, Profound's procedures have gained Medicare approval with rising insurance reimbursements. Despite a net loss of $8 million, the company improved gross margins to 74.3% and ended Q3 with $25 million cash, supporting near-term liquidity. With 70 systems installed and 93 in advanced sales stages, Profound aims for 75 installations by year-end, making it a notable small-cap growth stock in healthcare on the TSX.
Boeing stock heads into Monday after FAA moves 737 MAX 10 closer to approval — but a key snag remains
Previous Story

Boeing stock heads into Monday after FAA moves 737 MAX 10 closer to approval — but a key snag remains

Fiserv stock in focus: what to watch as FISV heads into Monday after “Unknown Shopper” launch
Next Story

Fiserv stock in focus: what to watch as FISV heads into Monday after “Unknown Shopper” launch

Go toTop